Primordial Dwarfism Registry
About the study
The goal of this registry is to collect information on individuals with Microcephalic Osteodysplastic Primordial Dwarfism Type II (also called MOPDII) and other forms of microcephalic primordial dwarfism. The study team hopes to learn more about these conditions and improve the care of people with it by establishing this registry.
Who can take part
You may be eligible to participate in the study if you meet the following criteria:
INCLUSION CRITERIA
Inclusion Criteria:
Individuals with MOPDII, MOPDI/III, Meier-Gorlin syndrome, or unclassified or closely related types of microcephalic primordial dwarfism as diagnosed by a medical provider are eligible for this registry.
EXCLUSION CRITERIA
Exclusion Criteria:
individuals without microcephalic primordial dwarfism or closely related conditions

Study Locations
Enter your ZIP code/Postal code/PIN code to locate study sites near you:
How to Apply
Contact the study center to learn if this study is a good match for you.
Study’s details
Contition
MOPDII,RNU4atac-opathy (e.g. MOPDI/III, Lowry-Wood Syndrome, Roifman Syndrome),Meier-Gorlin Syndrome,Saul-Wilson Syndrome,Ligase 4 Syndrome,Microcephalic Primordial Dwarfism
Participants needed
150
Est. Completion Date
Jan 1, 2030
Treatment type
Observational [Patient Registry]
Sponsor
Nemours Children's Clinic
ClinicalTrials.gov identifier
NCT04569149
Study number
MB001
Understanding Clinical Trials
Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?